Overview
- 11 inspections across 11 sites are on record.
- 13 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-09-22.
At a glance
Inspections
11
Sites
11
Observations
13
Career since
May 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shandong Anshun Pharmaceutical Co., Ltd. | 22 Sep 2023 | Human Drugs | |
| Shandong Xinhua Pharmaceutical Co Ltd. First Plant | 15 Sep 2023 | Human Drugs | |
| Cosette Pharmaceuticals NC Laboratories, LLC | 21 Jul 2023 | Human Drugs | View 483 → |
| Quality CDMO | 16 Jun 2023 | Human Drugs | View 483 → |
| B. L. Mitchell, Inc. | 28 Mar 2023 | Animal Drugs & Feeds |
Sites inspected
Shandong Anshun Pharmaceutical Co., Ltd.Dezhou, China1 insp.
Shandong Xinhua Pharmaceutical Co Ltd. First PlantZibo, China1 insp.
Cosette Pharmaceuticals NC Laboratories, LLCLincolnton, United States1 insp.
Quality CDMOFort Worth, United States1 insp.
B. L. Mitchell, Inc.Leland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Clinton J Lott6 shared
Martrice A Packer2 shared
Demario L Walls2 shared
Jennifer Lalama2 shared
Megan T Ziegler1 shared
Dorothy P Kramer1 shared
Harshal J Desai1 shared
Steven A Brettler1 shared
Marvin D Jones1 shared
Full investigator report
Get the verbatim findings behind Regan T Harp's 13 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site